The Nicotinic Cholinergic System and Cognitive Aging

PHASE1CompletedINTERVENTIONAL
Enrollment

104

Participants

Timeline

Start Date

October 1, 2016

Primary Completion Date

December 1, 2021

Study Completion Date

January 31, 2022

Conditions
Healthy Aging
Interventions
DRUG

Nicotine patch, oral mecamylamine, placebo

Each participant randomly receives one active drug or placebo on each of three study days.

Trial Locations (1)

05401

University of Vermont, Burlington

All Listed Sponsors
collaborator

Vanderbilt University Medical Center

OTHER

lead

University of Vermont

OTHER

NCT03408574 - The Nicotinic Cholinergic System and Cognitive Aging | Biotech Hunter | Biotech Hunter